Even if it's not a huge purchase, we think it was good to see that Samira Sakhia, the President of Knight Therapeutics Inc. (TSE:GUD) recently shelled out CA$95k to buy stock, at CA$4.75 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 12%.